Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 10:13:1040336.
doi: 10.3389/fimmu.2022.1040336. eCollection 2022.

Current status and development prospects of aquatic vaccines

Affiliations
Review

Current status and development prospects of aquatic vaccines

Yang Du et al. Front Immunol. .

Abstract

Diseases are a significant impediment to aquaculture's sustainable and healthy growth. The aquaculture industry is suffering significant financial losses as a result of the worsening water quality and increasing frequency of aquatic disease outbreaks caused by the expansion of aquaculture. Drug control, immunoprophylaxis, ecologically integrated control, etc. are the principal control strategies for fish infections. For a long time, the prevention and control of aquatic diseases have mainly relied on the use of various antibiotics and chemical drugs. However, long-term use of chemical inputs not only increases pathogenic bacteria resistance but also damages the fish and aquaculture environments, resulting in drug residues in aquatic products, severely impeding the development of the aquaculture industry. The development and use of aquatic vaccines are the safest and most effective ways to prevent aquatic animal diseases and preserve the health and sustainability of aquaculture. To give references for the development and implementation of aquatic vaccines, this study reviews the development history, types, inoculation techniques, mechanisms of action, development prospects, and challenges encountered with aquatic vaccines.

Keywords: aquaculture; aquatic vaccines; fish disease; fish immunity; genetic engineering vaccine; inactivated vaccine; liveattenuated vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Huy DTN, Nam VQ, Hanh HT, Minh PN, Huong LTT. A review and further analysis on seafood processing and the development of the fish pangasius from the food industry perspective. Food Sci Technol (2022) 42:e7642. doi: 10.1590/fst.76421 - DOI
    1. Mondal H, Thomas J. A review on the recent advances and application of vaccines against fish pathogens in aquaculture. Aquac Int (2022) 30:1971–2000. doi: 10.1007/s10499-022-00884-w - DOI - PMC - PubMed
    1. FAO . Food and agriculture organization of the united nations (2022). Available at: http://www.fao.org. - PubMed
    1. Sneeringer S, Bowman M, Clancy M. Economic research report 290026. United States: Department of Agriculture, Economic Research Service; (2019).
    1. Su H, van Eerde A, Steen HS, Heldal I, Haugslien S, Ørpetveit I, et al. . Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon salmo salar. Aquaculture (2021) 541:736806. doi: 10.1016/j.aquaculture.2021.736806 - DOI

Publication types